REQUEST A DEMO
Total
USD $0.00
Search more companies

Mip Pharma Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Research and Development in the Social Sciences and Humanities | Advertising Agencies | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Schools and Instruction | Other Personal and Household Goods Repair and Maintenance
Full name: Mip Pharma Polska Sp. z o.o. Profile Updated: April 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Mip Pharma Polska Sp. z o.o. operates as the Polish distribution and commercial platform of the MiP Pharma Group, supporting market access and supply to healthcare customers with a product focus aligned to the group portfolio. Business activity is centered on pharmaceutical distribution and sales/marketing execution, with emphasis on hospital-sector supply and selected specialist segments consistent with the group approach. The product footprint associated with the wider group includes hospital-relevant anti-infectives (including parenteral cephalosporins) and other prescription pharmaceuticals distributed via institutional and specialist channels, supported by local commercial operations. In Poland, the company is also associated with organizing medical conferences and training courses for physicians through a dedicated information and event platform, strengthening professional education touchpoints and stakeholder engagement. Geographic scope is Poland-focused with integration into the group network covering Germany, Poland and other Eastern European markets, alongside international sales reach in additional countries through the parent group. Key assets include affiliation with the MiP Pharma Group product and supply platform, a Poland-based commercial and distribution office, and a recurring physician-education/event capability supporting medical-community engagement. Strategic positioning focuses on dependable hospital and specialist-market supply of essential pharmaceuticals, leveraging group manufacturing/sourcing and portfolio strengths, and reinforcing market presence through structured sales/marketing and medical-education activities.

Headquarters
Ul. Orzechowa 5
Gdansk; Pomorskie; Postal Code: 80-175

Contact Details: Purchase the Mip Pharma Polska Sp. z o.o. report to view the information.

Website: http://www.mip-pharma.pl

Basic Information
Total Employees:
Purchase the Mip Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Mip Pharma Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Mip Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
September 17, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mip Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-6.73%
Total operating revenue
-7.58%
Operating Profit/Loss (EBIT)
-14.56%
EBITDA
-13.41%
Net Profit/Loss for the Period
-9.51%
Total Assets
14.34%
Total Equity
15.96%
Operating Profit Margin (ROS)
-1.51%
Net Profit Margin
-0.45%
Return on Equity (ROE)
-5.02%
Debt/Equity
-0.03%
Quick Ratio
6.93%
Cash Ratio
-0.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?